2nd Quarter - Report

THE MCMANUS GROUP for GENENTECH

Period 2nd Quarter 2018 Filed Jul 20, 2018 Signed by John McManus

Official filing
Firm
THE MCMANUS GROUP
Client
GENENTECH
Income
$40,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Medicare payment for inpatient antimicrobials.

Foreign entity interest: 100% ownership by F. Hoffman-La Roche Ltd., Grenzacherstrasse 124, CH-4070 Basel, SUI

LobbyistCovered position, as disclosed
BARRETT THORNHILL —

Contacted: Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Support for H.R. 4710 - 340B PAUSE Act. Reform of the 340B program.

Foreign entity interest: 100% ownership by F. Hoffman-La Roche Ltd., Grenzacherstrasse 124, CH-4070 Basel, SUI

LobbyistCovered position, as disclosed
JOHN MCMANUS —
BARRETT THORNHILL —

Contacted: Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE

Bills named: H.R. 4710 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.